(Q37857031)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21432941%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

Cholinesterase inhibitor use in Alzheimer's disease: the EPIFARM-Elderly Project (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21432941%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21432941%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Luca Merlino

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21432941%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Alessandro Nobili

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21432941%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Ugo Lucca

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21432941%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Mauro Tettamanti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21432941%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Emma Riva

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21432941%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Ida Fortino

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21432941%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Angela Bortolotti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21432941%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Luca Pasina

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21432941%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

1 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21432941%20AND%20SRC:MED&resulttype=core&format=json

Pharmacoepidemiology and Drug Safety

26 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21432941%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21432941%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21432941%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

497-505

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21432941%20AND%20SRC:MED&resulttype=core&format=json

Worldwide prevalence and incidence of dementia

26 January 2020

cites work

1 reference

A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.

21 January 2018

1 reference

A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group.

21 January 2018

1 reference

Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials

21 January 2018

1 reference

Alarming arbitrariness in EU prescription and reimbursement criteria for anti-dementia drugs

21 January 2018

1 reference

Prevalence of cholinesterase inhibitors in subjects with dementia in Europe

21 January 2018

1 reference

Antidepressant drug use in Lombardy, Italy: a population-based study

21 January 2018

1 reference

Incidence and etiology of dementia in a large elderly Italian population

21 January 2018

1 reference

A cohort study of effectiveness of acetylcholinesterase inhibitors in Alzheimer's disease

21 January 2018

1 reference

Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.

21 January 2018

1 reference

Eight-year prescription trends of memantine and cholinesterase inhibitors among persons 65 years and older in Germany

21 January 2018

1 reference

A population-based study of cholinesterase inhibitor use for dementia

21 January 2018

1 reference

Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's disease

21 January 2018

1 reference

Alzheimer Disease in the US Population

21 January 2018

1 reference

Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial

21 January 2018

1 reference

Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study.

21 January 2018

1 reference

Treatment persistency with rivastigmine and donepezil in a large state medicaid program

21 January 2018

1 reference

Drug persistency of two cholinesterase inhibitors: rivastigmine versus donepezil in elderly patients with Alzheimer's disease

21 January 2018

1 reference

A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients

21 January 2018

1 reference

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.

21 January 2018

1 reference

The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trial

21 January 2018

1 reference

Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease

21 January 2018

1 reference

Rivastigmine: an open-label, observational study of safety and effectiveness in treating patients with Alzheimer's disease for up to 5 years

21 January 2018

1 reference

Memantine in moderate-to-severe Alzheimer's disease

21 January 2018

1 reference

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

21 January 2018

1 reference